As of 2024-12-13, the Intrinsic Value of Edgewise Therapeutics Inc (EWTX) is
-6.56 USD. This EWTX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 29.80 USD, the upside of Edgewise Therapeutics Inc is
-122.02%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-6.56 USD
Intrinsic Value
EWTX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-6.56 - -6.56 |
-6.56 |
-122.02% |
| P/E |
(32.68) - (38.59) |
(35.61) |
-219.5% |
| DDM - Stable |
(14.98) - (102.95) |
(58.96) |
-297.9% |
| DDM - Multi |
(1.37) - (7.28) |
(2.30) |
-107.7% |
EWTX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2,821.76 |
| Beta |
2.90 |
| Outstanding shares (mil) |
94.69 |
| Enterprise Value (mil) |
2,776.96 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.64% |
| Cost of Debt |
5.00% |
| WACC |
5.77% |